Today: 27 January 2026
Subscribe
Browse Category

Pfizer News News 17 December 2025 - 17 January 2026

Pfizer stock slips into long weekend as PFE investors line up earnings, dividend dates

Pfizer stock slips into long weekend as PFE investors line up earnings, dividend dates

New York, Jan 16, 2026, 20:21 EST — Market closed. Pfizer shares slipped 0.9% to close at $25.65 on Friday, just ahead of the U.S. market’s long weekend. Trading volume hit roughly 58 million shares. (MarketScreener) The tape will be silent Monday as U.S. exchanges shut down for Martin Luther King Jr. Day. Trading resumes Tuesday’s regular session. (New York…
17 January 2026
·····
Pfizer stock flat before the bell as report flags 2026 U.S. drug price hikes, including 15% Comirnaty rise

Pfizer stock flat before the bell as report flags 2026 U.S. drug price hikes, including 15% Comirnaty rise

NEW YORK, December 31, 2025, 08:51 ET — Premarket Pfizer Inc shares were little changed in premarket trading on Wednesday after a report showed the drugmaker is leading a new round of U.S. list-price increases for 2026. The stock was down about 0.02% at $24.99, after closing Tuesday at roughly $25.00. The issue matters now because drug pricing has returned…
31 December 2025
····
Pfizer stock today: PFE holds near $25 as year-end trading turns to Fed minutes and next earnings

Pfizer stock today: PFE holds near $25 as year-end trading turns to Fed minutes and next earnings

NEW YORK, December 30, 2025, 03:31 ET — Market closed Pfizer Inc (PFE) shares were last down 0.3% at $25.00 in after-hours trading, after ending Monday at $25.09. The stock traded between $24.98 and $25.19 in the regular session. With U.S. markets in the final stretch of the year, volumes typically thin and position-adjusting can drive short-term moves. That leaves…
30 December 2025
····
Pfizer stock today: PFE edges down as Wall Street looks to Feb. 3 results update

Pfizer stock today: PFE edges down as Wall Street looks to Feb. 3 results update

NEW YORK, December 29, 2025, 2:08 PM ET — Regular session Pfizer shares dipped slightly on Monday, trading down about 0.1% at $25.06 as of 2:08 p.m. ET. The stock has moved between $24.99 and $25.19 in the regular session. The muted move matters because liquidity is thinning into year-end, leaving defensive names like large drugmakers more sensitive to sector…
29 December 2025
····
Pfizer Stock (NYSE: PFE) Holds Near $25 as Markets Close for the Weekend: Latest News, Analyst Targets, and What to Watch Monday

Pfizer Stock (NYSE: PFE) Holds Near $25 as Markets Close for the Weekend: Latest News, Analyst Targets, and What to Watch Monday

NEW YORK, Dec. 28, 2025, 2:50 p.m. ET — U.S. stock market closed (Sunday). Pfizer Inc. (NYSE: PFE) heads into the final week of 2025 with its shares hovering in the mid-$20s — a level Wall Street has increasingly framed as a “show-me” zone for investors who want evidence that Pfizer can navigate the post-COVID comedown and looming patent expirations…
28 December 2025
····
Pfizer Stock (PFE) Update: Shares Hold Near $25 Into Year-End as Investors Weigh 2026 Guidance, Dividend, and Pipeline Catalysts

Pfizer Stock (PFE) Update: Shares Hold Near $25 Into Year-End as Investors Weigh 2026 Guidance, Dividend, and Pipeline Catalysts

NEW YORK, Dec. 27, 2025, 3:07 p.m. ET — Market closed Pfizer Inc. (NYSE: PFE) is heading into the final trading days of 2025 with its stock still anchored in the mid-$20s, a range that has increasingly defined sentiment around the pharmaceutical giant as Wall Street debates two competing narratives: near-term pressure from fading COVID-era revenues and patent expirations, versus…
27 December 2025
····
Pfizer (PFE) Stock News, Forecasts and Analyst Outlook as of Dec. 25, 2025

Pfizer (PFE) Stock News, Forecasts and Analyst Outlook as of Dec. 25, 2025

Pfizer Inc. (NYSE: PFE) heads into Christmas Day with investors digesting a dense run of December headlines: a 2026 outlook that came in below Wall Street expectations, ongoing restructuring and cost-cutting, fresh U.S. drug-pricing initiatives that could reshape the industry’s economics, and multiple pipeline updates spanning oncology, immunology and cardiometabolic disease. U.S. markets are closed on Thursday, Dec. 25, 2025,…
25 December 2025
····
Pfizer Stock (PFE) Forecast and News: 2026 Guidance, Drug-Pricing Deals, and Pipeline Catalysts to Watch on Dec. 19, 2025

Pfizer Stock (PFE) Forecast and News: 2026 Guidance, Drug-Pricing Deals, and Pipeline Catalysts to Watch on Dec. 19, 2025

Pfizer Inc. (NYSE: PFE) stock was essentially flat on Friday, Dec. 19, 2025, trading around $25.04 in midday trading, after a volatile week that blended policy headlines, a reset of near-term financial expectations, and fresh pipeline updates. For investors, the story around Pfizer stock right now is less about a single headline and more about a three-way tug-of-war: Below is…
19 December 2025
····
Pfizer Stock (PFE) on Dec. 18, 2025: Latest News, 2026 Forecast, Analyst Price Targets, Dividend, and Key Catalysts

Pfizer Stock (PFE) on Dec. 18, 2025: Latest News, 2026 Forecast, Analyst Price Targets, Dividend, and Key Catalysts

Pfizer Inc. (NYSE: PFE) stock is trying to steady itself in late December after a volatile stretch driven by one big theme: the post-COVID hangover is still real, and 2026 is shaping up as another “rebuild” year—even as Pfizer spends aggressively to reload its pipeline. As of Thursday, Dec. 18, 2025, Pfizer shares traded around $25.04, down about 1.8% from…
18 December 2025
····
Pfizer Stock (PFE) After Hours Today (Dec. 17, 2025): What to Know Before the Market Opens Thursday

Pfizer Stock (PFE) After Hours Today (Dec. 17, 2025): What to Know Before the Market Opens Thursday

Pfizer (NYSE: PFE) finished Wednesday’s session lower and traded only modestly in the after-hours market—an indication that investors are still digesting the company’s newly issued 2026 outlook while weighing fresh pipeline headlines and looming U.S. policy risk around drug pricing. Below is a detailed look at where Pfizer stock stands after the bell on Dec. 17, 2025, what news moved…
18 December 2025
····
Pfizer Stock (PFE) Today: 2026 Guidance Triggers Fresh Scrutiny—News, Forecasts, Analyst Targets and Dividend Outlook (Dec. 17, 2025)

Pfizer Stock (PFE) Today: 2026 Guidance Triggers Fresh Scrutiny—News, Forecasts, Analyst Targets and Dividend Outlook (Dec. 17, 2025)

Pfizer Inc. stock (NYSE: PFE) is back in the spotlight on Wednesday, December 17, 2025, as investors digest the drugmaker’s newly issued 2026 outlook, a revised 2025 revenue view, and a longer runway to sustained growth than some shareholders had hoped for. Shares were trading around the mid-$25 range today, following a sharp reaction to the guidance update earlier this…
17 December 2025
···
Pfizer Stock (NYSE: PFE) News Today: 2026 Guidance, Earnings Forecasts, Analyst Price Targets and Key Catalysts

Pfizer Stock (NYSE: PFE) News Today: 2026 Guidance, Earnings Forecasts, Analyst Price Targets and Key Catalysts

December 17, 2025 Pfizer Inc. (NYSE: PFE) stock is back in the spotlight on December 17 as investors digest the company’s newly issued full-year 2026 financial guidance, along with a stack of fresh reporting and analyst commentary about what comes next for one of the world’s biggest drugmakers. The immediate market reaction has been skeptical: Pfizer’s outlook points to another…
17 December 2025
····
1 2

Stock Market Today

  • Euronext Dublin Announces De-Listing of Notes (CUSIP 635400WXSHQUMLW5BY28)
    January 27, 2026, 4:52 AM EST. Euronext Dublin has issued a notice regarding the de-listing of certain notes identified by CUSIP 635400WXSHQUMLW5BY28. The announcement follows regulatory protocols and involves securities previously traded on the market. Market participants should adjust their positions accordingly. Relevant data and references were sourced from ICE Data Services, FactSet, and other industry providers. This move affects trading operations on Euronext Dublin and reflects broader market adjustments.
Go toTop